BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 30

• 

  Georgiamune

  Georgiamune Inc. is a private, science and discovery clinical stage immunotherapeutic biotechnology company focused on reprogramming immune signaling pathways to redirect the immune system to fight diseases.
• 

  Nimble Therapeutics

  Nimble Therapeutics is a biotechnology company dedicated to delivering on the promise of oral peptide therapeutics. Leveraging a paradigm-shifting peptide drug discovery and development engine, Nimble is advancing its internal pipeline and continues to support several partnered programs.
• 

  BIOMILQ

  BIOMILQ is a women-owned and science-led mammary biotechnology start-up leveraging its patented technology to produce functional cell-cultured human milk components outside the body.
• 

  Imbed Biosciences

  Imbed Biosciences Inc. is a privately held medical device company emerging as a leader in the development of advanced synthetic therapies for the treatment of surgical wounds, burns, chronic ulcers, and soft-tissue repair.
• 

  Cabaletta Bio

  Cabaletta Bio is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies that have the potential to provide a deep and durable, perhaps curative, treatment for patients with autoimmune diseases.
• 

  Immunic Therapeutics

  Immunic is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases.
• 

  Remedy Plan Therapeutics

  Remedy Plan Therapeutics is a small molecule therapeutics start-up company transforming the field of NAMPT inhibition, with a pioneering approach that allows for hyperbolic inhibition of NAMPT that is highly tunable.
• 

  Phlow

  Phlow Corp. is a U.S.-based, public benefit corporation that develops and domestically manufactures APIs and finished pharmaceutical products that are critical to the nation’s healthcare.
• 

  Bonum Therapeutics

  Bonum Therapeutics is focused on a proven technology that utilizes regulation to create targeted, highly active, and less toxic medicines.
• 

  Delve Bio

  Delve Bio is a biotechnology company focused on improving precision medicine through cutting-edge genomic technology.